tetrafluoroaluminate has been researched along with bumetanide in 1 studies
Studies (tetrafluoroaluminate) | Trials (tetrafluoroaluminate) | Recent Studies (post-2010) (tetrafluoroaluminate) | Studies (bumetanide) | Trials (bumetanide) | Recent Studies (post-2010) (bumetanide) |
---|---|---|---|---|---|
170 | 1 | 10 | 2,033 | 150 | 354 |
Protein | Taxonomy | tetrafluoroaluminate (IC50) | bumetanide (IC50) |
---|---|---|---|
Solute carrier family 12 member 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chambard, JC; Paris, S; Pouysségur, J | 1 |
1 other study(ies) available for tetrafluoroaluminate and bumetanide
Article | Year |
---|---|
Coupling between phosphoinositide breakdown and early mitogenic events in fibroblasts. Studies with fluoroaluminate, vanadate, and pertussis toxin.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Amiloride; Animals; Bumetanide; Carrier Proteins; Chlorides; Cricetinae; Cricetulus; DNA Replication; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Fluorides; Fluorine; Hydrogen-Ion Concentration; Mitosis; Pertussis Toxin; Phosphatidylinositols; Sodium Fluoride; Sodium-Hydrogen Exchangers; Thrombin; Type C Phospholipases; Vanadates; Vanadium; Virulence Factors, Bordetella | 1987 |